Clinical Trials for EyePoint Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: EyePoint Pharmaceuticals

Clinical Trials (3)

NCT06683742
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
PHASE3Active, not recruiting
400 participants
Started: Nov 27, 2024 · Completed: Oct 31, 2027
2 conditions1 sponsor155 locations
NCT06668064
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56
PHASE3Active, not recruiting
400 participants
Started: Oct 22, 2024 · Completed: Aug 31, 2027
2 conditions1 sponsor85 locations
NCT05191706
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
PHASE4Recruiting
60 participants
Started: Jan 4, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor9 locations